Open Beta
MetriLume

US marketsXTNT

SEC-sourced researchBeta

XTNT

Xtant Medical Holdings, Inc.

Company comparison ↗

Data passport

CIK
0001453593
Exchange
NYSE
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Mar 31, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 117,267,000.0000 USD; December 2025: 133,927,000.0000 USD133.9M USD0 USD0December 2024December 2025
XTNT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024117,267,000.0000Mar 31, 2026
December 2025133,927,000.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025133,927,000.00004,973,000.000012,546,000.000094,145,000.000043,192,000.0000Mar 31, 2026
December 2024117,267,000.0000-16,449,000.0000-11,896,000.000093,837,000.000050,874,000.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$133.93MDecember 2025Mar 31, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$117.27MDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss$4.97MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$12.55MDecember 2025Mar 31, 202610-K
Total assetsAssets$94.15MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$43.19MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗